SEARCH WITHIN CONTENT
Citation Information : Immunohematology. Volume 23, Issue 3, Pages 120-129, DOI: https://doi.org/10.21307/immunohematology-2019-329
License : (Transfer of Copyright)
Published Online: 01-April-2020
The clinical course of warm autoimmune hemolytic anemia (WAIHA) can be perplexing and frustrating. Although many patients respond to standard therapy in a predictable and timely fashion, some patients are refractory to standard therapy and may require several attempts of therapies that are less well established. The focus of this review is to discuss the various pharmacologic approaches and options for the treatment of WAIHA.